Current and Previous Residents

Paulina Guevara, PharmD PGY1

• Areas of Interest: Cardiology, Critical Care, Ambulatory Care
• Education: University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
• Hometown: Los Angeles, CA
• Research Project: Evaluating the Use of Amiodarone After Lung Transplant in Patients with New Onset Atrial Arrhythmias
• MUE Project: Evaluation of Inpatient GLP-1 Use in Psychiatric Patients
• CE Project: Treatment of Multi-Drug-Resistant Gram-Negative Infections and the Role of Novel Beta-Lactams
• Why Temple? I chose Temple because it had everything I wanted for my residency training. I really wanted to be at a big academic medical center, at a place that serves a diverse population, at a program that is attached to a school of pharmacy, and at a hospital with a good variety of rotation options. I really enjoyed speaking to everyone on interview day and I had a good feeling about the support system Temple offers to their residents.
• Contact Information: [email protected]

Alyssa Khieu, PharmD PGY1

• Areas of Interest: Ambulatory Care, Addiction Medicine, Diabetes Management
• Education: University of Pittsburgh School of Pharmacy
• Hometown: Silverton, OR
• Research Project: Impact of Adjunctive Medications on Intensive Care Unit Length of Stay in Medetomidine-Associated Withdrawal
• MUE Project: Evaluation of inpatient Sublocade administration
• CE Project: Transition of Care Considerations for Incarcerated Patient
• Why Temple? I chose Temple because of their commitment to providing care to underserved communities. The residency program offers diverse learning opportunities in critical care and ambulatory care at an academic medical center, allowing you to experience a wide array of practice.
• Contact Information: [email protected]

Allie Lichvar, PharmD PGY1

• Areas of Interest: Critical Care, Emergency Medicine
• Education: Temple University School of Pharmacy (Philadelphia, PA)
• Hometown: Monroe, CT
• Research Project: Evaluating the Appropriateness of VTE Prophylaxis in Hospitalized Patients
• MUE Project: Extravasation Management
• CE Project: Behavioral Health – Focus on long-acting medications
• Why Temple? I chose Temple University Hospital's pharmacy residency program because of its deep commitment to serving the diverse and underserved population of Philadelphia—a mission that closely aligns with my own values. During my time at Temple’s School of Pharmacy, I had meaningful clinical experiences at the hospital that reinforced my desire to train in an environment known for its high acuity, strong interdisciplinary collaboration, and focus on patient-centered care.
• Contact Information: [email protected]

Caitlin Maskornick, PharmD PGY1

• Areas of Interest: Solid Organ Transplant
• Education: Northeastern University (Boston, MA)
• Hometown: Quakertown, PA
• Research Project: Comparison of Heparin vs DTI therapy for anticoagulation on patients receiving ECMO
• MUE Project: Evaluation of Tacrolimus Levels and Risk of Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant
• CE Project: Estimation of Renal Function - CrCl vs eGFR and the Implications of Drug Dosing
• Why Temple? I chose Temple University Hospital because it is a large academic medical center that serves a diverse patient population. Temple's supportive learning environment, broad range of clinic specialties and emphasis on interdisciplinary collaboration fosters a deep learning experience. I knew that gaining hands on patient experience while learning from preceptors of all different backgrounds would provide new perspectives and help me to become a better pharmacist. Temple's dedication to comprehensive training and a commitment to high quality, patient specific care allows residents to have a deeper understanding of pharmacy practice.
• Contact Information: [email protected]

Audrey Siana, PharmD PGY1

• Areas of Interest: Infectious Disease
• Education: Thomas Jefferson University (Philadelphia, PA)
• Hometown: Chester Springs, PA
• Research Project: Real world implementation of CAB/RPV (Treatment) and CAB (PrEP)
• MUE Project: Liposomal bupivacaine (Exparel)
• CE Project: Drug Supply Chain Security Act Go-Live – Goes live November 2025
• Why Temple? I chose Temple because the program offers a comprehensive and diverse clinical experience, allowing residents to tailor their training to their interests. During my interview, it was clear that the preceptors are supportive and dedicated to the residents. Temple practices a collaborative working environment across multiple healthcare professions, creating a beneficial learning environment as residents.
• Contact Information: [email protected]